interleukin 1beta (193-195) has been researched along with bradykinin in 1 studies
Studies (interleukin 1beta (193-195)) | Trials (interleukin 1beta (193-195)) | Recent Studies (post-2010) (interleukin 1beta (193-195)) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
---|---|---|---|---|---|
18 | 0 | 2 | 14,195 | 355 | 1,520 |
Protein | Taxonomy | interleukin 1beta (193-195) (IC50) | bradykinin (IC50) |
---|---|---|---|
B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cunha, FQ; Ferreira, SH | 1 |
1 review(s) available for interleukin 1beta (193-195) and bradykinin
Article | Year |
---|---|
Peripheral hyperalgesic cytokines.
Topics: Analgesics; Animals; Bradykinin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dexamethasone; Dinoprostone; Drug Evaluation, Preclinical; Hot Temperature; Humans; Hyperalgesia; Interleukin-1; Interleukin-1beta; Interleukins; Isoenzymes; Membrane Proteins; Nerve Growth Factor; Nociceptors; Pain Measurement; Peptide Fragments; Prostaglandin-Endoperoxide Synthases; Rats; Thalidomide; Tumor Necrosis Factor-alpha | 2003 |